Search research articles
Contact Us
Filters
Showing results (231-240 of 244) with videos related to
Page
of 25
Sort By:
The New England Journal of Medicine
|
April 24, 1997
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
M Sano, C Ernesto, R G Thomas, et al.
Molecular and Chemical Neuropathology
|
February 1, 1994
Neutral glycolipid composition of primary human brain tumors
L P Singh, D K Pearl, T K Franklin, et al.
JAMA
|
March 4, 2000
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study
R A Mulnard, C W Cotman, C Kawas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 24, 2006
Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation
Y Kaga, W J Shoemaker, M Furusho, et al.
Journal of Applied Clinical Medical Physics
|
September 14, 2023
AAPM Medical physics practice guideline 15.A: Peer review in clinical physics
Per H Halvorsen, Alan H Baydush, Courtney R Buckey, et al.
Journal of Applied Clinical Medical Physics
|
June 24, 2015
AAPM Medical Physics Practice Guideline 3.a: Levels of supervision for medical physicists in clinical training
J Anthony Seibert, Jessica B Clements, Per H Halvorsen, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study
M Sano, J A Mackell, M Ponton, et al.
Neurology
|
September 1, 1996
A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease
L J Thal, A Carta, W R Clarke, et al.
Human Molecular Genetics
|
November 5, 1997
A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43)
C B Eckman, N D Mehta, R Crook, et al.
Journal of Applied Clinical Medical Physics
|
December 5, 2019
AAPM medical physics practice guideline 7.a.: Supervision of medical physicist assistants
J Anthony Seibert, Anthony P Blatnica, Jessica B Clements, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 244) with videos related to
Sort By:
Page
of 25
The New England Journal of Medicine
|
April 24, 1997
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
M Sano, C Ernesto, R G Thomas, et al.
Molecular and Chemical Neuropathology
|
February 1, 1994
Neutral glycolipid composition of primary human brain tumors
L P Singh, D K Pearl, T K Franklin, et al.
JAMA
|
March 4, 2000
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study
R A Mulnard, C W Cotman, C Kawas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 24, 2006
Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation
Y Kaga, W J Shoemaker, M Furusho, et al.
Journal of Applied Clinical Medical Physics
|
September 14, 2023
AAPM Medical physics practice guideline 15.A: Peer review in clinical physics
Per H Halvorsen, Alan H Baydush, Courtney R Buckey, et al.
Journal of Applied Clinical Medical Physics
|
June 24, 2015
AAPM Medical Physics Practice Guideline 3.a: Levels of supervision for medical physicists in clinical training
J Anthony Seibert, Jessica B Clements, Per H Halvorsen, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study
M Sano, J A Mackell, M Ponton, et al.
Neurology
|
September 1, 1996
A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease
L J Thal, A Carta, W R Clarke, et al.
Human Molecular Genetics
|
November 5, 1997
A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43)
C B Eckman, N D Mehta, R Crook, et al.
Journal of Applied Clinical Medical Physics
|
December 5, 2019
AAPM medical physics practice guideline 7.a.: Supervision of medical physicist assistants
J Anthony Seibert, Anthony P Blatnica, Jessica B Clements, et al.
Page
of 25